| 000 | 01580 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513133238.0 | ||
| 264 | 0 | _c19980203 | |
| 008 | 199802s 0 0 eng d | ||
| 022 | _a0090-4295 | ||
| 024 | 7 |
_a10.1016/s0090-4295(97)00542-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGebrosky, N P | |
| 245 | 0 | 0 |
_aTreatment of renal cell carcinoma with 5-fluorouracil and alfa-interferon. _h[electronic resource] |
| 260 |
_bUrology _cDec 1997 |
||
| 300 |
_a863-7; discussion 867-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aNephrectomy |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aRemission Induction |
| 700 | 1 | _aKoukol, S | |
| 700 | 1 | _aNseyo, U O | |
| 700 | 1 | _aCarpenter, C | |
| 700 | 1 | _aLamm, D L | |
| 773 | 0 |
_tUrology _gvol. 50 _gno. 6 _gp. 863-7; discussion 867-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0090-4295(97)00542-6 _zAvailable from publisher's website |
| 999 |
_c9396168 _d9396168 |
||